Tirzepatide Clinics in District of Columbia
Compare Tirzepatide providers in District of Columbia. Check ratings, telehealth availability, and insurance acceptance to find the right prescriber.
Cities With Tirzepatide Providers in District of Columbia
All Tirzepatide Clinics in District of Columbia
Revolution Medicine, Health and Fitness
Weight Loss and Vitality
Gut Theory Total Digestive Care
Performance Rejuvenation Center
Composition ID Washington D.C.
Javan Wellness U Street
About Tirzepatide in District of Columbia
What is Tirzepatide?
Tirzepatide is a first-in-class dual GIP/GLP-1 receptor agonist developed by Eli Lilly. It uniquely targets both the GIP and GLP-1 receptors, producing greater weight loss and blood sugar control than GLP-1-only medications. Approved as Mounjaro for type 2 diabetes (2022) and Zepbound for weight management (2023), tirzepatide has shown weight loss of up to 22.5% in clinical trials — the highest of any GLP-1 class medication.
Brand Names
Tirzepatide is available as Mounjaro, Zepbound, manufactured by Eli Lilly.
Expected Weight Loss
In the SURMOUNT-1 trial, participants on tirzepatide 15 mg lost an average of 22.5% of their body weight over 72 weeks. At the 10 mg dose, average weight loss was 21.4%. Over a third (36%) on the highest dose lost 25% or more of their body weight, and 63% lost 20% or more.
Cost in District of Columbia
Without insurance, Tirzepatide typically costs $1,000-$1,200/month (Mounjaro), $1,000-$1,100/month (Zepbound). With insurance, costs range from $25-$200/month (varies by plan). Compounded options may be available at $250-$550/month.
Savings programs: Eli Lilly offers the Zepbound Savings Card (commercially insured patients may pay as low as $25/month) and the LillyDirect platform for direct-to-patient delivery.
Frequently Asked Questions
There are 7 clinics prescribing Tirzepatide (Mounjaro and Zepbound) in District of Columbia. Use the directory to compare providers by rating and location.
Yes, 7 of 7 Tirzepatide providers in District of Columbia (100%) offer telehealth. Most providers here support virtual visits, so you can start treatment without an office visit.
Brand-name Mounjaro and Zepbound costs $800–$1,400/month without insurance in District of Columbia. Compounded Tirzepatide from clinic weight loss programs typically runs $200–$500/month. With insurance, copays range from $25–$200/month depending on your plan's formulary and whether prior authorization is required.
Yes. Tirzepatide is a prescription medication in all US states including District of Columbia. You can get evaluated and prescribed through 7 telehealth providers in District of Columbia, or visit any of the 7 clinics listed here in person.
Coverage depends on your plan and diagnosis. Tirzepatide is widely covered for type 2 diabetes. For weight management, coverage is expanding — Wegovy and Zepbound now have broader approval, but many plans still require prior authorization or documented BMI criteria. Check with your insurer or ask the clinic to verify coverage before your appointment.
Related Articles
Zepbound vs Mounjaro: Understanding Tirzepatide Options
Zepbound and Mounjaro both contain tirzepatide but are approved for different conditions. Compare their dosing, cost, and insurance coverage.
costHow Much Does Mounjaro Cost Without Insurance in 2026?
Mounjaro's list price, savings programs, and what you can expect to pay out of pocket. Updated pricing for 2026.
medicationsGLP-1 Medications for Type 2 Diabetes vs Weight Loss: Key Differences
GLP-1 drugs treat both type 2 diabetes and obesity, but dosing, insurance coverage, and FDA approvals differ significantly between the two uses.